These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28866745)

  • 1. Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain.
    Nuño-Nuño L; Joven BE; Carreira PE; Maldonado-Romero V; Larena-Grijalba C; Cubas IL; Tomero EG; Barbadillo-Mateos MC; De la Peña Lefebvre PG; Ruiz-Gutiérrez L; López-Robledillo JC; Moruno-Cruz H; Pérez A; Cobo-Ibáñez T; Almodóvar González R; Lojo L; García De Yébenes MJ; López-Longo FJ
    Rheumatol Int; 2017 Nov; 37(11):1853-1861. PubMed ID: 28866745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry.
    Nuño-Nuño L; Joven BE; Carreira PE; Maldonado-Romero V; Larena-Grijalba C; Llorente Cubas I; Tomero E; Barbadillo-Mateos MC; García de la Peña Lefebvre P; Ruiz-Gutiérrez L; López-Robledillo JC; Moruno-Cruz H; Pérez A; Cobo-Ibáñez T; Almodóvar R; Lojo L; García de Yébenes MJ; López-Longo FJ
    Int J Rheum Dis; 2019 Aug; 22(8):1393-1401. PubMed ID: 30968571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease.
    Cobo-Ibáñez T; López-Longo FJ; Joven B; Carreira PE; Muñoz-Fernández S; Maldonado-Romero V; Larena-Grijalba C; Cubas IL; Muriel ET; Mateos CB; de la Peña Lefebvre PG; Gomez-Gomez A; Nogal LB; Pérez A; Almodovar R; Lojo L; Ruiz-Gutiérrez L; López-Robledillo JC; García de Yébenes MJ; Nuño-Nuño L
    Clin Rheumatol; 2019 Mar; 38(3):803-815. PubMed ID: 30392161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan.
    Yamasaki Y; Yamada H; Ohkubo M; Yamasaki M; Azuma K; Ogawa H; Mizushima M; Ozaki S
    J Rheumatol; 2011 Aug; 38(8):1636-43. PubMed ID: 21572147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients.
    Peng JM; Du B; Wang Q; Weng L; Hu XY; Wu CY; Shi Y
    PLoS One; 2016; 11(4):e0154441. PubMed ID: 27115138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Prognostic Factors Associated With Survival in Mexican Patients With Idiopathic Inflammatory Myopathies.
    Galindo-Feria AS; Rojas-Serrano J; Hinojosa-Azaola A
    J Clin Rheumatol; 2016 Mar; 22(2):51-6. PubMed ID: 26906295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study.
    Dobloug GC; Svensson J; Lundberg IE; Holmqvist M
    Ann Rheum Dis; 2018 Jan; 77(1):40-47. PubMed ID: 28814428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
    Bai Z; Shen G; Dong L
    Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of idiopathic inflammatory myopathies in South Africa.
    Chinniah KJ; Mody GM
    Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.
    Dobloug GC; Garen T; Brunborg C; Gran JT; Molberg Ø
    Semin Arthritis Rheum; 2015 Dec; 45(3):301-8. PubMed ID: 26190563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical course of idiopathic inflammatory myopathies: complications, survival and prognostic factors].
    Miró O; Laguno M; Alonso JR; Casademont J; Herrero C; Selva A; Urbano-Márquez A; Grau JM
    Med Clin (Barc); 1999 Apr; 112(14):521-6. PubMed ID: 10363237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why do patients with myositis die? A retrospective analysis of a single-centre cohort.
    Amaral Silva M; Cogollo E; Isenberg DA
    Clin Exp Rheumatol; 2016; 34(5):820-826. PubMed ID: 27494511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival analysis and risk factors for survival in idiopathic inflammatory myopathies: a retrospective cohort study].
    Yin G; Liang Y; Deng R; Wang Y; Xie QB; Zuo C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):818-22. PubMed ID: 24325120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases.
    Dankó K; Ponyi A; Constantin T; Borgulya G; Szegedi G
    Medicine (Baltimore); 2004 Jan; 83(1):35-42. PubMed ID: 14747766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of the outcome of patients with idiopathic inflammatory myopathy: a long-term follow-up study.
    Taborda AL; Azevedo P; Isenberg DA
    Clin Exp Rheumatol; 2014; 32(2):188-93. PubMed ID: 24447373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal relationship between idiopathic inflammatory myopathies and malignancies and its mortality: a nationwide population-based study.
    Sung YK; Jung SY; Kim H; Choi S; Im SG; Cha EJ; Jang EJ; Yoo DH; Cho SK
    Clin Rheumatol; 2020 Nov; 39(11):3409-3416. PubMed ID: 32372292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of patients with idiopathic inflammatory myopathies: anatomy of a single-centre cohort.
    Guimarães F; Yildirim R; Isenberg DA
    Clin Exp Rheumatol; 2023 Mar; 41(2):322-329. PubMed ID: 36861745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of idiopathic inflammatory myopathies in Western Australia: epidemiological characteristics and mortality over time.
    Nossent J; Keen H; Preen DB; Inderjeeth CA
    Rheumatol Int; 2024 Feb; 44(2):329-337. PubMed ID: 37819456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter registry on inflammatory myositis from the Rheumatology Society in Madrid, Spain: Descriptive Analysis.
    Nuño L; Joven B; Carreira P; Maldonado V; Larena C; Llorente I; Tomero E; Barbadillo MC; García-de la Peña P; Ruiz L; López-Robledillo JC; Moruno H; Pérez A; Cobo-Ibáñez T; Almodóvar R; Lojo L; Monteagudo I; García-De Yébenes MJ; López-Longo FJ
    Reumatol Clin; 2017; 13(6):331-337. PubMed ID: 27616211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.